Access to anti-retroviral drugs, female in Heavily indebted poor countries (HIPC)

Heavily indebted poor countries (HIPC): Access to anti-retroviral drugs, female was 86.6% in 2024. ◆ Volatile

Latest (2024)
86.6%
Change on year
up 4.2%
Rank
6th
of 19 groups
All-time high
86.6%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, female in Heavily indebted poor countries (HIPC), 2000–2024

0204060802000201220242000: 0 %2001: 0.012 %2002: 0.115 %2003: 0.445 %2004: 1.7 %2005: 3.6 %2006: 6.1 %2007: 10.4 %2008: 14.6 %2009: 18.3 %2010: 22.4 %2011: 26.6 %2012: 32.2 %2013: 38.2 %2014: 45.4 %2015: 50.1 %2016: 55.7 %2017: 62.2 %2018: 65.3 %2019: 69.2 %2020: 73.5 %2021: 76.2 %2022: 79.9 %2023: 83.1 %2024: 86.6 %

Source: UNAIDS estimates. Measured in %.

Analysis

The most recent figure for access to anti-retroviral drugs, female in Heavily indebted poor countries (HIPC) is 86.6%, measured in 2024. That is the highest value across all 25 years on record.

That represents a change of up 4.2% on the previous year and up 90.6% over ten years.

Over the whole period, access to anti-retroviral drugs, female in Heavily indebted poor countries (HIPC) peaked at 86.6% in 2024 and was at its lowest, 0.0%, in 2000.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, female in Heavily indebted poor countries (HIPC), year by year

Annual values for Access to anti-retroviral drugs, female (%) in Heavily indebted poor countries (HIPC), 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 0.1% +875.6%
2003 0.4% +286.6%
2004 1.7% +280.5%
2005 3.6% +112.3%
2006 6.1% +70.7%
2007 10.4% +69.4%
2008 14.6% +40.2%
2009 18.3% +25.5%
2010 22.4% +22.6%
2011 26.6% +18.4%
2012 32.2% +21.4%
2013 38.2% +18.6%
2014 45.4% +18.8%
2015 50.1% +10.4%
2016 55.7% +11.1%
2017 62.2% +11.7%
2018 65.3% +5.0%
2019 69.2% +6.1%
2020 73.5% +6.1%
2021 76.2% +3.7%
2022 79.9% +4.9%
2023 83.1% +4.0%
2024 86.6% +4.2%

Biggest year-on-year movements

Years where Access to anti-retroviral drugs, female in Heavily indebted poor countries (HIPC) changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2002 +875.6% 0.0% 0.1%
2003 +286.6% 0.1% 0.4%
2004 +280.5% 0.4% 1.7%

Averages by decade

DecadeAverage LowestHighest Years
2000s 5.5% 0.0% 18.3% 10
2010s 46.7% 22.4% 69.2% 10
2020s 79.8% 73.5% 86.6% 5

More gender data for Heavily indebted poor countries (HIPC)

All data for Heavily indebted poor countries (HIPC) →

Frequently asked questions

What is access to anti-retroviral drugs, female in Heavily indebted poor countries (HIPC)?
Access to anti-retroviral drugs, female in Heavily indebted poor countries (HIPC) was 86.6% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, female recorded in Heavily indebted poor countries (HIPC)?
The highest recorded value was 86.6% in 2024.
What is the lowest access to anti-retroviral drugs, female recorded in Heavily indebted poor countries (HIPC)?
The lowest recorded value was 0.0% in 2000.
How does Heavily indebted poor countries (HIPC) rank for access to anti-retroviral drugs, female?
Heavily indebted poor countries (HIPC) ranks 6th out of 19 groups with data for 2024.
Is access to anti-retroviral drugs, female rising or falling in Heavily indebted poor countries (HIPC)?
Over the last ten years it is up 90.6%. The long-run trend across the full record is volatile.
Where does this Heavily indebted poor countries (HIPC) data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, female in Heavily indebted poor countries (HIPC). Statizoid, drawing on UNAIDS estimates. Retrieved 14 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/heavily-indebted-poor-countries-hipc/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/heavily-indebted-poor-countries-hipc/">Access to anti-retroviral drugs, female in Heavily indebted poor countries (HIPC)</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, female (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,925 data points, 2000–2024
Last refreshed

The percentage of adult females living with HIV who are receiving antiretroviral therapy.